Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. It also provides over the counter products, including SprinJene, an oral care product; and RAF FIVE, a dermatology product, as well as Zyraydi, an enhanced distillate capture and dissolution matrix technology. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is headquartered in Perth, Australia.
| Market Capitalization | $11.1202 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | 2.803 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.55 |
| EBITDA | -6,740.154 |
| Profit Margin | 0 |
| Operating Margin TTM | -23.7917 |
| Return on Assets TTM | -0.1251 |
| Return on Equity TTM | -0.186 |
| Revenue TTM | 301.121 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2004-06-30 | 501.043 | 141.289 | 359.754 | 1,037.592 |
| 2005-06-30 | 569.479 | 178.191 | 391.288 | 860.642 |
| 2006-06-30 | 140.691 | 70.66 | 140.691 | 1,407.022 |
| 2007-06-30 | 21,079.158 | -3,847.85 | 24,927.008 | 46,550.123 |
| 2008-06-30 | 23 | 487.993 | ||
| 2009-06-30 | 129 | 733 | 1,854.688 | |
| 2010-06-30 | 34.25 | 46 | 34.25 | 1,150.316 |
| 2011-06-30 | 498 | 44 | 463.082 | |
| 2012-06-30 | 29 | 7 | 630.627 | |
| 2013-06-30 | 29 | 5 | 29.134 | 322.062 |
| 2014-06-30 | 21 | 12 | 20.738 | 295.177 |
| 2015-06-30 | 11.59 | 12 | 8.906 | 423.828 |
| 2016-06-30 | 2.73 | 36 | 300 | 876.421 |
| 2017-06-30 | 167.76 | 0 | 100.042 | 6,324.469 |
| 2018-06-30 | 561.39 | 0 | 313.757 | 2,828.197 |
| 2019-06-30 | 859.17 | 859.169 | 4,238.383 | |
| 2020-06-30 | 1,040.38 | 7,936.793 | ||
| 2021-06-30 | 663.316 | 228.222 | 435.094 | 10,195.523 |
| 2022-06-30 | 1,540.624 | 939.054 | 601.57 | 14,247.027 |
| 2023-06-30 | 301.121 | 362.56 | -61.439 | 7,201.691 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2004-06-30 | 2,152.071 | 8,541.987 | 252.174 | 8,401.826 | ||
| 2005-06-30 | 1,459.904 | 10,022.529 | 143.064 | 10,303.146 | ||
| 2006-06-30 | 1,961.613 | 26,451.096 | 11,575.633 | 2,847.853 | 156 | 14,428.467 |
| 2007-06-30 | 228.936 | 9,272.294 | 24,115.704 | 3,317.391 | 24,819.594 | |
| 2008-06-30 | 1,093.704 | 1,399.219 | 123.059 | 28,324.594 | ||
| 2009-06-30 | 2,707.79 | 3,547.237 | 1,069.028 | 798 | 14,947.129 | |
| 2010-06-30 | 343.355 | 694.954 | 40.626 | 14,947.129 | ||
| 2011-06-30 | 787.96 | 875.294 | 213.941 | 14,947.129 | ||
| 2012-06-30 | 1,278.52 | 1,431.423 | 79.206 | 15,961.851 | ||
| 2013-06-30 | 969.305 | 1,078.498 | 38.124 | 15,961.851 | ||
| 2014-06-30 | 597.534 | 780.163 | 30.006 | 15,961.851 | ||
| 2015-06-30 | 324.596 | 408.266 | 50.395 | 15,969.645 | ||
| 2016-06-30 | 55.692 | 87.518 | 290.424 | 1,000 | 16,307.505 | |
| 2017-06-30 | 7,867.854 | 7,967.156 | 70.625 | 0 | 13,803.411 | |
| 2018-06-30 | 5,685.725 | 6,313.814 | 99.423 | 0 | 13,823.411 | |
| 2019-06-30 | 3,073.125 | 3,515.198 | 407.235 | 0 | 13,823.411 | |
| 2020-06-30 | 1,697.04 | 35,788.634 | 1,241.709 | 60.862 | 26,075.6 | |
| 2021-06-30 | 4,971.116 | 39,365.699 | 1,536.06 | 90.534 | 36,651.436 | |
| 2022-06-30 | 2,746.409 | 37,701.491 | 2,010.953 | 116.709 | 43,745.957 | |
| 2023-06-30 | 146.206 | 33,890.713 | 2,178.913 | 142.528 | 45,515.996 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2004-06-30 | -2,751.702 | 1,252.481 | 899.59 | 2,152.071 | ||
| 2005-06-30 | -311.668 | -2,563.859 | -692.167 | 2,152.071 | 1,459.904 | |
| 2006-06-30 | -901.336 | -7,088.027 | 501.709 | 1,459.904 | 1,961.613 | |
| 2007-06-30 | -38,161.916 | -14,809.64 | -1,732.677 | 1,961.613 | 228.936 | |
| 2008-06-30 | 12,614.569 | -2,211.296 | 864.768 | 228.936 | 1,093.704 | |
| 2009-06-30 | -20,270.809 | -1,571.261 | 1,614.086 | 1,093.704 | 2,707.79 | |
| 2010-06-30 | -1,687.993 | -1,182.623 | -2,364.435 | 2,707.79 | 343.355 | |
| 2011-06-30 | 7.025 | 101.925 | 444.605 | 343.355 | 787.96 | |
| 2012-06-30 | -637.958 | -572.818 | 490.56 | 787.96 | 1,278.52 | |
| 2013-06-30 | -311.843 | -259.894 | -309.215 | 1,278.52 | 969.305 | |
| 2014-06-30 | -290.217 | -276.254 | -371.771 | 969.305 | 597.534 | |
| 2015-06-30 | -400.08 | -292.893 | -272.938 | 597.534 | 324.596 | |
| 2016-06-30 | -898.637 | -331.818 | -268.904 | 324.596 | 55.692 | 0 |
| 2017-06-30 | -6,157.415 | -1,600.153 | 7,145.79 | 722.064 | 7,867.854 | 0 |
| 2018-06-30 | -1,729.806 | -2,624.947 | -2,182.129 | 7,867.854 | 5,685.725 | |
| 2019-06-30 | -3,567.802 | -3,344.223 | -2,612.6 | 5,685.725 | 3,073.125 | |
| 2020-06-30 | -7,015.045 | -6,936.276 | -1,376.085 | 3,073.125 | 1,697.04 | |
| 2021-06-30 | -8,549.079 | -8,616.594 | 3,274.076 | 1,697.04 | 4,971.116 | |
| 2022-06-30 | -12,467.366 | -11,878.823 | -2,224.707 | 4,971.116 | 2,746.409 | |
| 2023-06-30 | -5,573.007 | -7,249.078 | -2,600.203 | 2,746.409 | 146.206 |